DK108789C - Fremgangsmåde til fremstilling af 9α-chlor- eller 9α-fluor-16(α eller β)-alkylderivater af prednison og prednisolon. - Google Patents

Fremgangsmåde til fremstilling af 9α-chlor- eller 9α-fluor-16(α eller β)-alkylderivater af prednison og prednisolon.

Info

Publication number
DK108789C
DK108789C DK550163AA DK550163A DK108789C DK 108789 C DK108789 C DK 108789C DK 550163A A DK550163A A DK 550163AA DK 550163 A DK550163 A DK 550163A DK 108789 C DK108789 C DK 108789C
Authority
DK
Denmark
Prior art keywords
prednisolone
prednisone
fluoro
chloro
preparation
Prior art date
Application number
DK550163AA
Other languages
English (en)
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Application granted granted Critical
Publication of DK108789C publication Critical patent/DK108789C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • C07J71/0052Nitrogen only at position 16(17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DK550163AA 1957-07-22 1958-07-21 Fremgangsmåde til fremstilling af 9α-chlor- eller 9α-fluor-16(α eller β)-alkylderivater af prednison og prednisolon. DK108789C (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67314157A 1957-07-22 1957-07-22
US733843A US3164618A (en) 1957-07-22 1958-05-08 Alkylated steroids
US5031460A 1960-08-18 1960-08-18

Publications (1)

Publication Number Publication Date
DK108789C true DK108789C (da) 1968-02-12

Family

ID=27367724

Family Applications (3)

Application Number Title Priority Date Filing Date
DK550163AA DK108789C (da) 1957-07-22 1958-07-21 Fremgangsmåde til fremstilling af 9α-chlor- eller 9α-fluor-16(α eller β)-alkylderivater af prednison og prednisolon.
DK385560AA DK109512C (da) 1957-07-22 1958-07-21 Fremgangsmåde til fremstilling af 16(αellerβ)-alkyderivater af cortison, hydrocortison, prednison eller prednisolon eller 21-estrene af disse forbindelser.
DK267258AA DK105334C (da) 1957-07-22 1958-07-21 Fremgangsmåde til fremstilling af 16β-alkylderivater af cortison, hydrocortison, prednison eller prednisolon eller 21-estrene af disse forbindelser.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK385560AA DK109512C (da) 1957-07-22 1958-07-21 Fremgangsmåde til fremstilling af 16(αellerβ)-alkyderivater af cortison, hydrocortison, prednison eller prednisolon eller 21-estrene af disse forbindelser.
DK267258AA DK105334C (da) 1957-07-22 1958-07-21 Fremgangsmåde til fremstilling af 16β-alkylderivater af cortison, hydrocortison, prednison eller prednisolon eller 21-estrene af disse forbindelser.

Country Status (7)

Country Link
US (2) US3164618A (da)
CY (1) CY576A (da)
DE (2) DE1286034B (da)
DK (3) DK108789C (da)
FR (1) FR1326306A (da)
GB (2) GB901092A (da)
MY (1) MY7100134A (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947409A (en) * 1958-06-19 1976-03-30 Merck & Co., Inc. 16-Alkyl-1,4,9(11)-pregnatrienes and 9,11-epoxides thereof
PT2805720T (pt) 2008-05-28 2019-09-23 Reveragen Biopharma Inc Moduladores esteroides não hormonais de nf-kb para tratamento de uma doença
CN101417912B (zh) * 2008-11-10 2012-11-14 湖南玉新药业有限公司 制备倍他米松醋酸酯的方法
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
CN105017377B (zh) * 2015-07-06 2018-02-16 湖南新合新生物医药有限公司 肾上腺皮质激素药物中间体的制备方法
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
WO2020191087A1 (en) 2019-03-18 2020-09-24 Ptc Therapeutics, Inc. Therapeutic combinations for use in treating a muscular dystrophy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741732A (en) * 1951-12-08 1955-12-14 Upjohn Co Steroid compounds
GB736182A (en) * 1952-07-16 1955-09-07 Upjohn Co Halogenation of steroid compounds
US2790799A (en) * 1952-11-27 1957-04-30 Syntex Sa Cyclopentanophenanthrene derivatives and process for the production thereof
GB748914A (en) * 1953-05-13 1956-05-16 Glidden Co Improvements in or relating to preparation of 21-halo steroids
US2932656A (en) * 1957-06-19 1960-04-12 Merck & Co Inc Production of delta1, 4-3, 20-diketopregnadienes from the corresponding semicarbazones

Also Published As

Publication number Publication date
MY7100134A (en) 1971-12-31
GB901093A (en) 1962-07-11
US3164618A (en) 1965-01-05
GB901092A (en) 1962-07-11
FR1326306A (fr) 1963-05-10
DE1286034B (de) 1969-01-02
DK109512C (da) 1968-05-06
DE1181705B (de) 1964-11-19
CY576A (en) 1971-02-15
US3461117A (en) 1969-08-12
DK105334C (da) 1966-09-19

Similar Documents

Publication Publication Date Title
DK126687B (da) Analogifremgangsmåde til fremstilling af glucofuranosider eller 2-0-acylderivater deraf.
DK108789C (da) Fremgangsmåde til fremstilling af 9α-chlor- eller 9α-fluor-16(α eller β)-alkylderivater af prednison og prednisolon.
DK119556B (da) Fremgangsmåde til fremstilling af 9α-fluor-16β-methyl-derivater af hydrocortison eller prednisolon eller 21-acetater deraf.
DK103939C (da) Fremgangsmåde til fremstilling af 17-estere 18-homo-19-nortestosteron eller 3-enolacylater deraf.
DK128606B (da) Fremgangsmåde til fremstilling af 16β-metylprednison eller 21-acetatet deraf.
DK101415C (da) Fremgangsmåde til fremstilling af 16-halogenmethylen-17α-hydroxy-20-keto-steroider af pregnan-, 19-norpregnan- eller iso-pregnanrækken eller 17α-estere deraf.
DK94042C (da) Fremgangsmåde til fremstilling af 17β-hydroksy-17α-alkynylsteroider af androstanrækken.
DK114898B (da) Fremgangsmåde til fremstilling af 20-halogen-3-keto-steroider af pregnanrækken eller 17-halogen-3-ketosteroider af androstanrækken.
DK108138C (da) Fremgangsmåde til fremstilling af 16α-methyl-11β, 17 α, 21-trihydroxy-4-pergnen-3, 20-dion.
DK89185C (da) Fremgangsmåde til fremstilling af 17α,21-dihydroxy-20-keto-steroider af pregnanrækken.
DK104972C (da) Fremgangsmåde til fremstilling af spiramycin II eller spiramycin III eller blandinger deraf.
DK107812C (da) Fremgangsmåde til fremstilling af deserpidin eller reserpin.
DK90357C (da) Fremgangsmåde til fremstilling af 9α-hydroxy- eller 8α-hydroxysteroider.
DK90284C (da) Fremgangsmåde til fremstilling af 2,6-bis-ethyleniminohydroquinon og 2,3,5-triethyleniminobenzoquinon-(1,4).
DK87198C (da) Fremgangsmåde til fremstilling af 4-hydroxy-cumariner eller 1-thia-4-hydroxy-cumariner.
DK96234C (da) Fremgangsmåde til fremstilling af 16α-methyl-pregnan-3α-acetat-11,20-dion.
DK99569C (da) Fremgangsmåde til fremstilling af 9α-fluor-16α-hydroxy-1-dehydrocortison eller estere heraf.
DK104674C (da) Fremgangsmåde til fremstilling af 19-nor-steroidforbindelser af androstan- eller pregnanrækken.
DK89145C (da) Fremgangsmåde til fremstilling af 17-20,20-21-bismethylendioxysteroider af pregnanrækken.
DK89256C (da) Fremgangsmåde til fremstilling af 17-20,20-21-bisalkylidendioxysteroider af pregnanrækken.
DK93675C (da) Fremgangsmåde til fremstilling af 21-fluor-9α-halogen-11β-hydroxy-steroider af pregnanrækken.
DK90286C (da) Fremgangsmåde til fremstilling af phenazinderivater.
DK97648C (da) Fremgangsmåde til fremstilling af 17α-acyloksy-16α-metyl-4-pregnen-3,20-dion-derivater eller 17α-acyloksy-16α-metyl-4,6-pregnadien-3,20-dion-derivater.
DK98002C (da) Fremgangsmåde til fremstilling af 11β,17α,21-trihydroxy-16α-methyl-4-pregnen-3,20-dion.
DK103668C (da) Fremgangsmåde til fremstilling af 11-oxygenerede 6-methyl-1,4-pregnadiener eller 21-acylestere deraf.